The authors reply

New England Journal of Medicine

Volumn 371, Issue 1, 2014, Pages 86-87

  Maynard, Michelle A ^a   Huang, Stephen A ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; HYPOXIA INDUCIBLE FACTOR 1; IODOTHYRONINE DEIODINASE 3; OXIDOREDUCTASE; PROTEIN TYROSINE KINASE INHIBITOR; SONIC HEDGEHOG PROTEIN; SUNITINIB; UNCLASSIFIED DRUG; IODIDE PEROXIDASE; THYROID HORMONE;

BASAL CELL CARCINOMA; BREAST CANCER; COLON CANCER; FIBROMA; GASTROINTESTINAL STROMAL TUMOR; HEMANGIOENDOTHELIOMA; HEMANGIOMA; HUMAN; HYPOTHYROIDISM; LETTER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; ENZYMOLOGY; GASTROINTESTINAL TUMOR; MALE; METABOLISM; NOTE;

GASTROINTESTINAL NEOPLASMS; GASTROINTESTINAL STROMAL TUMORS; HUMANS; HYPOTHYROIDISM; IODIDE PEROXIDASE; MALE; THYROID HORMONES;

EID: 84903690902     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1405198     Document Type: Letter

References (5)

1. Huang SA, Tu HM, Harney JW, et al. Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas. N Engl J Med 2000;343:185-9. (Pubitemid 30489216)
2. Huang SA, Bianco AC. Reawakened interest in type III iodothyronine deiodinase in critical illness and injury. Nat Clin Pract Endocrinol Metab 2008;4:148-55. (Pubitemid 351301780)
3. Hamnvik OP, Larsen PR, Marqusee E. Thyroid dysfunction from antineoplastic agents. J Natl Cancer Inst 2011;103:1572-87.
4. Gereben B, Zavacki AM, Ribich S, et al. Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling. Endocr Rev 2008;29:898-938.
5. Desai J, Yassa L, Marqusee E, et al. Hypothyroidism after sunitinib treatment for patients with gastrointestinal stromal tumors. Ann Intern Med 2006;145:660-4. (Pubitemid 46768841)